Shares

7 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2021

Feb 14, 2022

SELL
$238.08 - $288.0 $3.86 Million - $4.67 Million
-16,207 Closed
0 $0
Q3 2021

Nov 09, 2021

BUY
$250.72 - $291.24 $91,512 - $106,302
365 Added 2.3%
16,207 $4.32 Million
Q2 2021

Aug 09, 2021

BUY
$235.0 - $310.7 $8,460 - $11,185
36 Added 0.23%
15,842 $4.34 Million
Q1 2021

May 05, 2021

SELL
$175.6 - $291.43 $975,809 - $1.62 Million
-5,557 Reduced 26.01%
15,806 $4.28 Million
Q4 2020

Feb 09, 2021

BUY
$174.98 - $272.83 $85,040 - $132,595
486 Added 2.33%
21,363 $3.74 Million
Q3 2020

Nov 06, 2020

SELL
$185.27 - $238.73 $62,991 - $81,168
-340 Reduced 1.6%
20,877 $4.06 Million
Q2 2020

Aug 07, 2020

BUY
$153.32 - $191.72 $3.25 Million - $4.07 Million
21,217 New
21,217 $3.8 Million

Others Institutions Holding PEN

About Penumbra Inc


  • Ticker PEN
  • Exchange NYSE
  • Sector Healthcare
  • Industry Medical Devices
  • Shares Outstandng 37,888,400
  • Market Cap $9.01B
  • Description
  • Penumbra, Inc. designs, develops, manufactures, and markets medical devices in the United States and internationally. The company offers aspiration based thrombectomy systems and accessory devices, including revascularization device for mechanical thrombectomy, such as Penumbra System under the Penumbra RED, JET, ACE, 3D Revascularization Device...
More about PEN
Track This Portfolio

Track Commerce Bank Portfolio

Follow Commerce Bank and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Commerce Bank, based on Form 13F filings with the SEC.

News

Stay updated on Commerce Bank with notifications on news.